138 participants
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2026-05-18
- Completion:
- 2028-09-30
Conditions
- Large Cell Neuroendocrine Carcinoma
- Large Cell Pulmonary Neuroendocrine Carcinoma of the Lung (LCNEC)
- Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
- Small Cell Lung Cancer (SCLC)
- Gastroenteropancreatic NEC (GEP NEC)
- NEC of the Bladder
- Other DLL3 Expressing epNEC
Interventions
- DRUG
- OTHER
No Results Yet